Advanced search    

Search: Oncology

173,057 papers found. Showing first 1,000 results.
Use AND, OR, NOT, +word, -word, "long phrase", (parentheses) to fine-tune your search.

Correction to: Vaccination with nanoparticles combined with micro-adjuvants protects against cancer

two affiliations: 9) Department of dermatology, University of Zurich, Bern, Switzerland and 10) Department of Oncology, University of Lausanne, Bern,Switzerland should be replace with 9) Department of ... should be replaced Paul Engeroff. Furthermore, there are two errors in the following affiliations: 9) Department of dermatology, University of Zurich, Bern, Switzerland and 10) Department of Oncology

Overview of Oncology and Hematology Drug Approvals at US Food and Drug Administration Between 2008 and 2016

We previously conducted an overview of oncology products reviewed by the Office of Oncology Drug Products in the Center for Drug Evaluation and Research at the US Food and Drug Administration for ... that occurred after 2007 had any impact on the regulatory drug approvals. We present a detailed overview of hematology and oncology products reviewed by Office of Oncology Drug Products and Office of

Herausforderungen und Zukunftsperspektiven in der Neuroonkologie

Neuro-oncology is a young and emerging discipline. An interdisciplinary mindset and concerted actions in specialized expert teams are required to meet the challenges, not only in clinical patient ... , translational and clinical research can be used for improving the sometimes extremely limited and prognostically unsatisfactory treatment options. The continuously developing spectrum of tasks in neuro-oncology

Integrating radiation oncology into the management of pancreatic cancer

. Tempero MA, et al. NCCN clinical practice guideline in oncology pancreatic Adenocarcinoma version 2.2017. J Natl Compr Canc Netw. 2017;15(8):1028–61.  https://doi.org/10.6004/jnccn.2017.0131 ... treatment followed by capecitabine-based chemoradiation for borderline resectable pancreatic cancer: Alliance for clinical trials in oncology trial A021101. Jama Surg. 2016;151:e161137.CrossRefGoogle Scholar

Recent advances in circulating nucleic acids in oncology

Circulating cell-free DNA (cfDNA) is one of the fastest growing and most exciting areas in oncology in recent years. Its potential clinical uses cover now each phase of cancer patient management care ... review relates the recent advances in the application of circulating DNA or RNA in oncology building on unpublished or initial findings/work presented at the 10th international symposium on circulating

Artificial intelligence for precision oncology: beyond patient stratification

The data-driven identification of disease states and treatment options is a crucial challenge for precision oncology. Artificial intelligence (AI) offers unique opportunities for enhancing such ... such predictive capabilities in the lab and the clinic. AI, including its best-known branch of research, machine learning, has significant potential to enable precision oncology well beyond relatively

Early experience with Watson for oncology in Korean patients with colorectal cancer

Background Watson for oncology (WFO) is a cognitive computing system providing decision support. We evaluated the concordance rates between the treatment options determined by WFO and those ... College of Medicine, Incheon, Republic of Korea, 2 Division of Oncology, Department of Internal Medicine, Gachon University Gil Medical Center, Gachon University College of Medicine, Incheon, Republic of

Safety of Novel Targeted Therapies in Oncology

targeted therapies in oncology across a range of pharmacotherapeutic classes. Procaccio and colleagues [7] reviewed approved as well as investigational antiangiogenic and vascular disrupting agents in the ... profiling: a single center study. Cancer Res. 2016;76:3690–701.CrossRefGoogle Scholar 5. Sánchez NS, Mills GB, Mills Shaw KR. Precision oncology: neither a silver bullet nor a dream. Pharmacogenomics

Primary vascular bone tumors in the spine: a challenge for pathologists and spine oncology surgeons

PurposePrimary vascular bone tumors of the spine represent a challenge for oncology surgeons, due to the need of planning a surgical strategy appropriate to the tumor behavior. But these tumors ... terminology and a more detailed classification [1, 2, 3]. As a consequence, primary vascular tumors of bone represent a serious diagnostic and therapeutic pitfall for oncology surgeons. The anatomical

Preface ‘Changing Trend in Peritoneal Surface Oncology in Asian Countries’

Preface First Online: 12 February 2019 Since the early phase of emergence of peritoneal surface oncology as an oncologic specialty, Asia has contributed to developing innovative therapies chiefly ... treatment of peritoneal surface malignancies comprising of cytoreductive surgery and intraperitoneal chemotherapy is one of most complex surgical procedures in oncology. Both multidisciplinary expertise and

Exploring the needs and resources of children in a haematology-oncology unit

Too often a child's body is restored to health in the hospital, but the child is sent home with emotional wounds. This study explored the needs of children in a haematology-oncology unit as well as ... field study was then conducted in order to prioritise the resources according to their importance for children in a haematology-oncology unit. A definite trend could be found in the way that the children

Japanese structure survey of radiation oncology in 2010

We evaluated the evolving structure of radiation oncology in Japan in terms of equipment, personnel, patient load, and geographic distribution to identify and overcome any existing limitations. From ... limitations. From March 2011 to June 2013, the Japanese Society for Radiation Oncology conducted a questionnaire based on the Japanese national structure survey of radiation oncology in 2010. Data were analyzed

Value-based medicine in oncology: the importance of perspective in the emerging value frameworks

implement value frameworks in oncology are the European Society of Medical Oncology (ESMO), the American Society of Clinical Oncology (ASCO), the Memorial Sloan Kettering Cancer Center (MSKCC) and the ... oncology and the importance of perspective for framework readiness to support healthcare decision-making based on MCDA methodology. Key words: Neoplasms; Drug Costs; Decision Support Techniques; Clinical

What is happening with the supply of oncology drugs in Brazil and the world?

Campinas - UNICAMP, Campinas, SP, Brazil Corresponding author     The continuity of the supply of drugs used in oncology and oncohematology, which are on the whole irreplaceable, has been the cause ... related to the quality of available products as the vast majority of the 'old' drugs used in oncology are products considered 'similar medications', whose origin, bioequivalence, production process and

Carbon-ion radiotherapy for lymph node oligo-recurrence: a multi-institutional study by the Japan Carbon-Ion Radiation Oncology Study Group (J-CROS)

wish to thank the members of the Working Group of Metastatic Tumors, part of the Japan Carbon-Ion Radiation Oncology Study Group, for their constructive criticism and advice. This research did not

Prognostic and Predictive Epigenetic Biomarkers in Oncology

There is a broad spectrum of epigenetic biomarkers in oncology, but those related to methylation and microRNA (miRNA) copy number variation or changed expression seem to be the most promising. There ... , it seems that miRNAs and circulating tumor DNA are the most promising biological material to work with in personalized oncology. 1 Introduction Genetic information is provided by the order of

Oncolytic virus immunotherapy: future prospects for oncology

biologyCancer Immunoediting Background Scope of Immuno-oncology Medical oncology is in the midst of a massive paradigm shift: previously markedly toxic and poorly selective systemic chemotherapy and ... -years for advanced cancers. Notably, such treatments are able to induce up to total regression or remission [5, 6]. Intriguingly though the principle of immuno-oncology has long existed. Historically

Seamless Designs: Current Practice and Considerations for Early-Phase Drug Development in Oncology

Oncology annual meetings from 2010 to 2017 for FiH trials enrolling at least 100 patients. We identified 1786 early-phase trials enrolling 57 559 adult patients. Fifty-one of the trials (2.9%) investigated ... bestowed on 5.1% of oncology drugs initiating trials between 2006 and 2015, translating advances in preclinical knowledge into effective cancer treatments has been difficult historically (1). An average of

Long-term efficacy and cost-effectiveness of blended cognitive behavior therapy for high fear of recurrence in breast, prostate and colorectal Cancer survivors: follow-up of the SWORD randomized controlled trial

National Trial Register ( NTR4423 ) on 12-Feb-2014. This abstract was previously presented at the International Psycho-Oncology Society conference of 2018 and published online. (Psycho-oncology, 27(S3):8-55 ... -oncology. 2013;22(1):1–11. https://doi.org/10.1002/pon.3022.View ArticlePubMedGoogle ScholarLebel S, Tomei C, Feldstain A, Beattie S, McCallum M. Does fear of cancer recurrence predict cancer survivors

Learning from data to predict future symptoms of oncology patients

Effective symptom management is a critical component of cancer treatment. Computational tools that predict the course and severity of these symptoms have the potential to assist oncology clinicians ... evidence, [ 1?3 ] as well as clinical experience suggests that the symptom experience of oncology patients is extremely variable. While some patients experience very few symptoms, other patients undergoing